NutriBand (NTRB) Non-Current Debt (2016 - 2026)
NutriBand's (NTRB) quarterly Non-Current Debt came in at $35861.0 in Q1 2026, down 38.39% year-on-year from $58205.0 in Q1 2025, and down 13.8% quarter-over-quarter from $41603.0 in Q4 2025.
NutriBand (NTRB) Non-Current Debt (2016 - 2026) Analysis & Trends
NutriBand has disclosed Non-Current Debt across 10 years of filings, most recently posting $35861.0 for Q1 2026.
- Non-Current Debt for Q1 2026 came in at $35861.0, down 38.39% year-over-year; the trailing twelve-month figure through Jan 2026 was $35861.0 (down 38.39% YoY), and the FY2026 annual result was $35861.0, down 38.39% from the prior year.
- Non-Current Debt came in at $35861.0 for Q1 2026 at NutriBand, down from $41603.0 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $115749.0 in Q2 2022 to a low of $35861.0 in Q1 2026.
- The 5-year median for Non-Current Debt is $79826.0 (2024), against an average of $78364.5.
- Across the five-year window, Non-Current Debt rose 7.1% in 2022 and tumbled 38.39% in 2026, its largest moves.
- NutriBand's Non-Current Debt stood at $105512.0 in 2022, then retreated by 19.34% to $85101.0 in 2023, then slipped by 25.13% to $63717.0 in 2024, then sank by 34.71% to $41603.0 in 2025, then declined by 13.8% to $35861.0 in 2026.
- The last three Non-Current Debt figures came in at $35861.0 (Q1 2026), $41603.0 (Q4 2025), and $47290.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | 35,861.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 35,861.00 |
| Jan 31, 2026 | 35,861.00 |
| Oct 31, 2025 | 41,603.00 |
| Oct 31, 2025 | 41,603.00 |
| Jul 31, 2025 | 47,290.00 |
| Jul 31, 2025 | 47,290.00 |
| Apr 30, 2025 | 52,632.00 |
| Apr 30, 2025 | 52,632.00 |
| Jan 31, 2025 | 58,205.00 |
| Jan 31, 2025 | 58,205.00 |
| Oct 31, 2024 | 63,717.00 |
| Oct 31, 2024 | 63,717.00 |
| Jul 31, 2024 | 69,133.00 |
| Jul 31, 2024 | 69,133.00 |
| Apr 30, 2024 | 74,509.00 |
| Apr 30, 2024 | 74,509.00 |
| Jan 31, 2024 | 79,826.00 |
| Jan 31, 2024 | 79,826.00 |
| Oct 31, 2023 | 85,101.00 |
| Oct 31, 2023 | 85,101.00 |